Advertisement

Picture EBD Group BioPharm America 2019 Boston September 600x60px
Document › Details

Paion AG. (11/7/12). "Press Release: Paion AG. Interim Report by Management for the Second Half of the Year 2012 According to § 37X WpHG for the Period from 1 January to 30 September 2012". Aachen.

Organisations Organisation Paion AG
  Group Paion (Group)
  Organisation 2 Ono Pharmaceutical Co., Ltd. (TSE: 4528)
  Group Ono Pharmaceutical (Group)
Products Product desmoteplase
  Product 2 Remifentanil (INN)
  Index term 2 Lundbeck–Paion: desmoteplase, 201202 acquisition all remaining desmoteplase rights for €20.1m in cash from Paion
Person Person Söhngen, Wolfgang (Paion 200603 CEO)
     


   
Record changed: 2019-06-09

Advertisement

Picture [LSUS] Life-Sciences-USA.com – The Business Web Portal 600x60px

More documents for Paion (Group)


To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

To get even more information, please take a look at our [gs] professional services offering and read the gene-sensor Product Flyer [PDF file]

Advertisement

SilverSky LifeSciences DxPx Conference 2019 Düsseldorf Medica 600x60px




» top